Initial predictors of development of pure red cell aplasia in myasthenia gravis after thymectomy

Clinical Neurology and Neurosurgery

Volumn 106, Issue 1, 2003, Pages 16-18

  Suzuki, Shigeaki ^a   Nogawa, Shigeru ^a   Tanaka, Kortaro ^a   Koto, Atsuo ^a   Fukuuchi, Yasuo ^a   Kuwana, Masataka ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

HLA class II; Myasthenia gravis; Pure red cell aplasia; Thymectomy

Indexed keywords

AUTOANTIBODY; AZATHIOPRINE; CHOLINERGIC RECEPTOR; CHOLINESTERASE INHIBITOR; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; PREDNISONE;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD; CHILD; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; IMMUNOLOGY; MAJOR CLINICAL STUDY; MALE; MYASTHENIA GRAVIS; ONSET AGE; POSTOPERATIVE COMPLICATION; PREDICTION; PREVALENCE; PURE RED CELL ANEMIA; REMISSION; RISK FACTOR; THYMECTOMY; THYMOMA; TREATMENT OUTCOME;

EID: 0344982901     PISSN: 03038467     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0303-8467(03)00061-1     Document Type: Article

References (12)

1. Drachman D.B. Myasthenia gravis. N. Engl. J. Med. 330:1994;1797-1810.
2. Erslev A.J., Soltan A. Pure red cell aplasia: a review. Blood Rev. 10:1996;20-28.
3. Mamiya S., Itoh T., Miura A.B. Acquired pure red cell aplasia in Japan. Eur. J. Haematol. 59:1997;199-205.
4. Oosterhuis H.J.G.H., Feltkamp T.E.W., van Rossum A.L., van den Berg-Loonen P.M., Nijenhuis L.E. HLA antigens, autoantibody production and associated disease in thymoma patients, with and without myasthenia gravis. Ann. NY Acad. Sci. 274:1976;468-474.
5. Socinski M.A., Ershler W.B., Frankel J.P., Albertini R.J., Ciongoli A.K., Krawitt E.L., Burns S.L., Mangan K.F. Pure RBC aplasia and myasthenia gravis. Arch. Intern. Med. 143:1983;543-546.
6. Bailey R.O., Dunn H.G., Rubin A.M., Ritaccio A.L. Myasthenia gravis with thymoma and pure red blood cell aplasia. Am. J. Clin. Pathol. 89:1988;687-693.
7. Mizobuchi S., Yamashiro T., Nonami Y., Yamamoto A., Kume M., Nakaya H., Sawada T., Taguchi H., Moriki T., Ogoshi S. Pure red cell aplasia and myasthenia gravis with thymoma: a case report and review of the literature. Jpn. J. Clin. Oncol. 28:1998;696-701.
8. Jaretzki A. III, Barohn R.J., Ernstoff R.M., Kaminski H.J., Keesey J.C., Penn A.S., Sanders D.B. Myasthenia gravis: recommendations for clinical research standards. Neurology. 55:2000;16-23.
9. Suzuki S., Kuwana M., Yasuoka H., Tanaka K., Fukuuchi Y., Kawakami Y. Heterogeneous immunogenetic background in Japanese adults with myasthenia gravis. J. Neurol. Sci. 189:2001;59-64.
10. Evoli A., Minisci C., Di Schino C., Marsili F., Punzi C., Batocchi A.P., Tonali P.A., Doglietto G.B., Granone P., Trodella L., Cassano A., Lauriola L. Thymoma in patients with MG. Characteristics and long-term outcome. Neurology. 59:2002;1844-1850.
11. Masaoka A., Monden Y., Nakahara K., Tanioka T. Follow-up study of thymomas with special reference to their clinical stages. Cancer. 48:1981;2485-2492.
12. Masaoka A., Hashimoto T., Shibata K., Yamakawa Y., Nakamae K., Iizuka M. Thymomas associated with pure red cell aplasia. Histologic and follow-up studies. Cancer. 64:1989;1872-1878.